Souvie Biodelivery LLC received a $225,000 Project Grant award from the National Science Foundation Division of Industrial Innovation on February 15, 2021 to develop a novel drug delivery system using engineered exosomes. The award is part of NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and innovation. Under the award, Souvie Biodelivery will work to advance its exosome-based drug delivery platform technology over the one-year period ending January 31, 2022. If successful, the company's engineered exosome system could enable new approaches for targeted therapeutic delivery.
Generated 1/6/24, 8:38 PM